We will be back to our regular posting schedule on Tuesday, September 4th.
Wolters Kluwer Holiday
September 3, 2012 by
Health | Wolters Kluwer Legal & Regulatory U.S.
Health & the Law, Analysis and Information
FDA Press Releases
- FDA approves first chemoimmunotherapy regimen for patients with relapsed or refractory diffuse large B-cell lymphoma June 26, 2019
- FDA Statement on the FDA’s ongoing investigation into valsartan and ARB class impurities and the agency’s steps to address the root causes of the safety issues June 26, 2019
- FDA issues warnings to companies selling illegal, unapproved kratom drug products marketed for opioid cessation, pain treatment and other medical uses June 26, 2019
- First FDA-approved vaccine for the prevention of dengue disease in endemic regions June 26, 2019